Gram negative rods related to animal sources (Zoonotic organisms)

Bookmark (0)
Please login to bookmark Close
  • Briefly describe Brucellosis
    • Brucellosis is a zoonotic disease. Brucella abortus (Cattle), Brucella melitensisi (Sheep goat and cattle), Brucella suis (pigs), Brucella canis (dogs). Brucella abortus is more common in prevalence. Tissues affected in animals include mammary glands (ease of transmission), epididymis and seminal vesicles (sterility), uterus and placenta (abortions). Brucella sheds ni urine, stool, and POCs (Products of Conception – placenta, amniotic fluid) remain viable in the environment for ≥ 40 days.
    • Brucella is a gram negative coccobacili (may imitate hemophilus), non-encapsulated, no motile, non spore forming. They are oxidase catalse, and urease positive but non-lactose fermenters. Difficult to culture but use of castaneda bottle or biphasic culture media for up to 6 weeks. Automated culture systems may take up to 7 days.
    • Epidemiology
      • Global distribution, increasing number of cases. Expansion of animal rearing without adequate education. Consumption of “health” foods and travel to endemic areas.
  • Outline the causative agents of Brucellosis Cause Brucellosis/ undulant fever/ Mediterranean fever/ Malta fever
    1. Brucella arbotus- cattle
    2. Brucella suis- swine
    3. Brucella melitensis- goats/ sheep
    4. Brucella canis- dogs
    5. Brucella bovis- goats/ sheep(no evidence it affects man)
  • Outline the characteristics of Brucella
    1. GN coccobacilli occurring singly, in chains or in groups.
    2. Non motile, non sporing, non capsulated
    3. Strict aerobes, grow very slowly (fastidious) on blood agar
    4. Facultative intracellular pathogens
    5. Do not ferment CHOs
    6. Difficult to culture- Castaneda bottle or biphasic culture media for up to 6 weeks
  • Briefly describe the pathogenesis and transmission of Brucellosis
    • Ingestion of contaminated unpasteurized products (milk), Ingestion of raw meat, bone marrow, liver, direct contact with infected animals, inhalaton (meat processing factories, lab workers), entry through cut woumds or breaks)
    • At risk individuals
      • Livestock farmers, pastoralists, abattori workers, vets (Trans-placental transmission), consumers of unpasteurized animal products
    • Enters host → not picked up by TLRs (some eukaryotic cell membrane feaatures) → access intraepithelial spaces (immune avoidance) → triggers phagocytosis by macrophages 0> Inhibit macrophage MPO and phagolysosome → trafficked by macrophages to RES (Liver sinusoids, spleen, BM, Lymph nodes) → Multiply in the ER of macrophages → Formation of granulomas (important clinical feature of disease persistence)
    • Erythritol – alcohol based compound that is highly nutritious for brucella, found in placentla tissue
  • Outline the clinical features of Brucellosis
    • Incubation 1-3 weeks to months
    • Undulating fevers, drenching, worse in the late afternoon or evening. Can pesist for weeks, months, or years
    • Associated myalgia, headache, joint (spine) pain and anorexia
    • Weight loss – directly proportaionl to duration of illness
    • Enlarged RES Splenomegaly > lymphadenpathy or hepatomegaly
    • Other organs involved – Lung, bone, brain, heart, GUT
  • What are the complications of Brucellosis
    • MSK disease localization and complications
    • CVS omplications
    • Pulmonary manifestation (Rare)
    • Genitourinary disease
    • Neurobrucellosis
    • Pregnancy related complications (abortion not common in humans
    • Dermatological findings
    • Vaccine related complications (splash effect to conjuctiva when injecting animals)
  • Outline the clinical features, treatment, and prevention of Brucellosis
    • Culture: Blood, bone marrow
    • Serology: Tube agglutination that measures Abs against smooth LPS
      • Non-endemic dz → titres higher than 1:160 + clinical features
      • Endemic dz → titres higher than 1:320 + clinical features
      • Potential cross creacton with IgM of francisella, salmonella urbana, yersinia enterocolita serotype O9, Vibrio cholerae, Alpha cleverlandensis, and some other bacteria
    • PCR
    • Imaging
      • Spinal radiography: Sacroiliitis, Spondylitis
      • Ultrasonography: Heart
      • Radionuclide scintigraphy
      • CT scan
    • Biopsy
    • Treatment
      • Monotherapy associated with high relapse rates (40%)
      • Doxycycine with either rifampicin for at least 5 weeks
      • Doxycycline with streptomycin
    • Prevention
      • Vaccination, Pasteurization, Changing cultural dietary habit
  • Briefly describe the transmission of Yersinia pestis
    1. Sylvatic (enzootic)phase: in forest infections of rodents, squirrels, rabbits, field rats.
    2. Urban plague: transmission of the bacteria among urban rats with the rat flea as the vector. Also domestic cats infected by eating infected rodents. Pets may bring infected fleas into the home
    3. Human to human:
    a) inhalation- through respiratory droplets of secretions of infected persons b) flea bite- from infected humans with bacilli in their blood to susceptible ones.
  • What are the laboratory features of Yersinia pestis Specimens: fluid or material aspirated from buboes/ other tissues; sputum, blood
    1. Gram stain: GN coccobacilli, demonstrate bipolar staining with Giemsa, Wayons or Methylene Blue
    2. Culture:
    • Cefsulodin, Irgasan,Novobiacin (CIN) agar– selective for Yersinia and Aeromonas spp. Bull’s eye appearance
    • SBA, MacConkey agar: autolyses after 2-3 days on Mac, pink but not a LF. On SBA small transparent colonies that enlarge wit prolonged incubation
    1. Biochemical tests: catalase positive. Oxidase, citrate and indole negative
    2. Motility test- non motile at 18-22°C
    3. Direct immunofluorescence
    4. Serological tests: complement fixation + hemagglutination
    5. Dipstick Ag: immunochromatography test for buboe aspirates and sputum
Jeffrey Kalei
Jeffrey Kalei
Articles: 335

Leave a Reply

Your email address will not be published. Required fields are marked *